General description
Ceftriaxone is a third-generation cephalosporin.
INN
Ceftriaxone
ATC codes
Medicine type
Chemical agent
Antibiotic groups
EML status history
First added in 1995
(TRS
867)
for
Bacterial infection of unspecified site
Added in 2017
(TRS
1006)
for
Bacterial meningitis
Added in 2017
(TRS
1006)
for
Osteomyelitis or osteitis
Added in 2017
(TRS
1006)
for
Bacterial infection of joint
Added in 2017
(TRS
1006)
for
Sepsis without septic shock
Added in 2017
(TRS
1006)
for
Infectious gastroenteritis or colitis without specification of infectious agent
Added in 2017
(TRS
1006)
for
Gonococcal infection
Added in 2017
(TRS
1006)
for
Peritoneal abscess
Added in 2017
(TRS
1006)
for
Peritonitis
Removed in 2017
(TRS
1006)
for
Bacterial infection of unspecified site
Added in 2017
(TRS
1006)
for
Bacterial pneumonia
Added in 2017
(TRS
1006)
for
Other specified pneumonia
Added in 2017
(TRS
1006)
for
Acute pyelonephritis
Added in 2017
(TRS
1006)
for
Inflammatory and other diseases of prostate
Added in 2019
(TRS
1021)
for
Typhoid fever
Added in 2019
(TRS
1021)
for
Paratyphoid fever
Added in 2021
(TRS
1035)
for
Necrotising fasciitis
Added in 2021
(TRS
1035)
for
Endophthalmitis
Wikipedia
DrugBank
Recommendations
Section
Watch group antibiotics
- Parenteral > General injections > unspecified: 250 mg in vial powder for injection (as sodium salt); 1 g in vial powder for injection (as sodium salt)
- Parenteral > General injections > unspecified: 250 mg in vial powder for injection (as sodium salt); 500 mg in vial powder for injection (as sodium salt); 1 g in vial powder for injection (as sodium salt); 2 g in vial powder for injection (as sodium salt)
- Parenteral > General injections > unspecified: 250 mg in vial powder for injection (as sodium salt); 500 mg in vial powder for injection (as sodium salt); 1 g in vial powder for injection (as sodium salt)
- Parenteral > Locoregional injections > Intravitreal: 250 mg in vial powder for injection (as sodium salt); 500 mg in vial powder for injection (as sodium salt); 1 g in vial powder for injection (as sodium salt); 2 g in vial powder for injection (as sodium salt)
- Parenteral > General injections > unspecified: 2 g in vial; 250 mg in vial powder for injection (as sodium salt); 500 mg in vial powder for injection (as sodium salt); 1 g in vial powder for injection (as sodium salt)
Indications
First choice
Typhoid fever Paratyphoid fever Bacterial meningitis Other specified pneumonia (Hospital-acquired pneumonia) Bacterial pneumonia (Community-acquired pneumonia - severe) [children] co-prescribed with amikacin Inflammatory and other diseases of prostate (severe) co-prescribed with amikacin Acute pyelonephritis (severe) co-prescribed with azithromycin Gonococcal infection co-prescribed with clarithromycin Bacterial pneumonia (Community-acquired pneumonia - severe) co-prescribed with metronidazole Necrotising fasciitis co-prescribed with metronidazole Peritonitis (mild-moderate) co-prescribed with metronidazole Peritoneal abscess (severe) co-prescribed with metronidazole Peritonitis (severe) co-prescribed with metronidazole Peritoneal abscess (mild-moderate) co-prescribed with vancomycin Endophthalmitis
Other indications